How CARB-X project support works
CARB-X provides financial, scientific and business support to accelerate the development of products focused on the most serious drug-resistant bacteria identified by the WHO and CDC. The goal is to support them through the early stages of product development and Phase 1 so they can attract private or public investment for further clinical stage development.
Part of the funds may be provided through our partnership with the UK’s Global AMR Innovation Fund (GAMRIF) to support the economic development and welfare of developing countries through the ‘Official Development Assistance’ (ODA) program. For more information about what projects might qualify for ODA funding, please click here.
Funded companies are required to meet high standards in all their research and business activities, including in animal and human testing, reporting and compliance. For more information about Research Compliance, please click here.
CARB-X is unique in that, in addition to funding, it provides scientific and business support through the CARB-X Global Accelerator Network, a group of accelerators from around the world each specialized in areas that are essential to product development. For more information about the Global Accelerator Network, please click here.
- For specific questions about the application process, scope of funding or contractual requirements, please contact email@example.com